RNS Number : 6732M
Avingtrans PLC
18 September 2023
 

18 September 2023

Avingtrans Plc

 

("Avingtrans" or the "Group")

 

 

Completion of Acquisition of Adaptix Ltd

 

Further to its announcement on 13 July 2023 and following approval under the UK National Security & Investment Act, Avingtrans plc is pleased to announce that it has completed the acquisition of the remaining issued and to be issued share capital of Adaptix Ltd, the emerging MedTech business based in Oxford, for a total consideration of up to £2.7m (the "Acquisition") to be satisfied by the issue of 642,355 ordinary shares of 5p each in the Company ("Ordinary Shares") at 426 pence per Ordinary Share ("Consideration Shares").

 

Avingtrans has been supporting Adaptix over the past few months through a loan facility from the Company of £1.1m and has agreed to adopt debt facilities of £2.1m. In addition to repaying a renegotiated sum to various debt and creditors of £2.2m on behalf of Adaptix.

 

Issue of Equity

 

Application has been made for the admission to trading on AIM for the 642,355 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 21 September 2023.

 

Total Voting Rights

 

Following the issue of the 642,355 Consideration Shares, the Company will have a total of 32,892,800 Ordinary Shares in issue. The Company does not hold any shares in Treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

 

 

ENDS

 

 

 

Enquiries:

 

Avingtrans plc

Les Thomas, Interim Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

01354 692391

Singer Capital Markets (Nominated Adviser and Broker)

Shaun Dobson

Alex Bond

Oliver Platts

 

02074 963000

IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Zach Cohen

020 3934 6630

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton, Nottingham & East Kilbride, UK and USA, China and India

 

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

 

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

 

Stainless Metalcraft Ltd - Chatteris, UK

 

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

 

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

 

Design, manufactures and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

 

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

 

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

 

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

 

Tecmag Inc, Houston, USA

 

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFLFSRATIELIV